The globalcervical dysplasia marketsize is expected to reach USD 936.4 million by 2028 according to a new study by Polaris Market Research.The report “Cervical Dysplasia Market Share, Size, Trends, Industry Analysis Report, By Type (Diagnostic Tests, {HPV Test, Pap Smear Test, Biopsy Test}, Diagnostic Devices, Colposcope); By End-Use (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers), By Regions; Segment Forecast, 2021 – 2028”gives a detailed insight into current market dynamics and provides analysis on future market growth.
宫颈癌的普遍性和关于其早期诊断的意识是关键的宫颈发育不良行业影响因素。根据世界卫生组织发布的报告，2018年，全球约有5,70,000例宫颈癌患者，并记录了超过3,11,000人死亡。据报道，HPV是女性中颈椎发育不良的原因因素。
此外，宫颈意识月由美国国会引入2019年，宣布1月份致力于患有市场宫颈癌的患者。政府控制下的国家宫颈癌联盟负责突出与疾病相关的问题和早期诊断的重要性。这些政府支持的举措必然会增加有关疾病筛查的认识，预计会提高宫颈发育不良的市场增长。
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below://m.ptlymt.com/industry-analysis/cervical-dysplasia-market/request-for-sample
Market participants such as Qiagen N.V., Abbott Laboratories, Hologic, Inc., Quest Diagnostics, DYSIS Medical Ltd, Micromedic Technologies Ltd., OncoHealth Corporation, Inc., CooperSurgical Inc., and Roche are some of the key players operating in the global market for cervical dysplasia. The companies in the marketplace for cervical dysplasia are focussing on collaborations and agreement to survive in the highly regulated market with huge patient unmet needs.
For instance, in January 2020, both Japan pharmaceutical giants ASKA Pharmaceutical and KinoPharma entered into a collaborative agreement for the development and commercialization of drug candidates for cervical dysplasia in the market, which is under preclinical phase under KinoPharma. Under the agreement, ASKA would obtain exclusive rights to sell the drug in the Japanese market and will help later in co-developing potential drug candidates and KinoPharma in return will receive upfront payments for the exclusive licensing.
早些时候，2019年7月，Roche将其在全球访问计划下扩大了其产品组合，包括HPV和新兴国家结核病诊断产品，特别是在HPV患病率最高的国家。这种扩张是对资源限制国家的宫颈发育不良进行成本效益的治疗，并实施多个大规模计划。
Polaris Market research has segmented the cervical dysplasia market report on the basis of type, end-use, and region:
Cervical Dysplasia, by Type Outlook (Revenue – USD Million, 2016 – 2028)
- 诊断测试
- HPV测试
- Pap Smear Test
- Biopsy Test
- Diagnostic Devices
- Copposcope.
Cervical Dysplasia, by End-Use Outlook (Revenue – USD Million, 2016 – 2028)
- 医院
- 诊断中心
- Ambulatory Surgical Centers
颈椎发育不良，区域前景（收入 - 百万，2016 - 2028）
- 北美
- U.S.
- Canada
- Europe
- France
- Germany
- 英国
- Italy
- Spain
- 荷兰
- 奥地利
- 亚太地区
- 中国
- India
- 日本
- Malaysia
- 韩国
- 印度尼西亚
- 中美洲和南美洲
- Mexico
- Brazil
- Argentina
- 中东和非洲
- 阿联酋
- 沙特阿拉伯
- Israel
- 南非